{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T00:14:31Z","timestamp":1794960871875,"version":"4.9.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T00:00:00Z","timestamp":1686528000000},"content-version":"am","delay-in-days":284,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ajo.2022.04.022","type":"journal-article","created":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T04:42:43Z","timestamp":1651812163000},"page":"120-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Comparison of the Effects of Latanoprostene Bunod and Timolol on Retinal Blood Vessel Density: A Randomized Clinical Trial"],"prefix":"10.1016","volume":"241","author":[{"given":"Nevin W.","family":"El-Nimri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasan","family":"Moghimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5566-569X","authenticated-orcid":false,"given":"Rafaella C.","family":"Penteado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Ghahari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diya","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Brye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Proudfoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4768-0624","authenticated-orcid":false,"given":"Jiun L.","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5954-5257","authenticated-orcid":false,"given":"Andrew","family":"Camp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7015-7017","authenticated-orcid":false,"given":"Matthew","family":"Salcedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9553-3202","authenticated-orcid":false,"given":"Robert N.","family":"Weinreb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajo.2022.04.022_bib0001","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0896-1549(01)00012-8","article-title":"Glaucomatous optic neuropathy: mechanisms of disease","volume":"15","author":"Halpern","year":"2002","journal-title":"Ophthalmol Clin North Am"},{"key":"10.1016\/j.ajo.2022.04.022_bib0002","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archopht.120.6.701","article-title":"The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma","volume":"120","author":"Kass","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2022.04.022_bib0003","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","article-title":"Reduction of intraocular pressure and glaucoma progression: Results from the Early Manifest Glaucoma Trial","volume":"120","author":"Heijl","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2022.04.022_bib0004","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archopht.121.1.48","article-title":"Factors for glaucoma progression and the effect of treatment: The early manifest glaucoma trial","volume":"121","author":"Leske","year":"2003","journal-title":"Arch Ophthalmol"},{"issue":"18","key":"10.1016\/j.ajo.2022.04.022_bib0005","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: a review","volume":"311","author":"Weinreb","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ajo.2022.04.022_bib0006","doi-asserted-by":"crossref","first-page":"271","DOI":"10.7326\/0003-4819-158-4-201302190-00008","article-title":"Comparative effectiveness of treatments for open-angle glaucoma: a systematic review for the U.S. preventive services task force","volume":"158","author":"Boland","year":"2013","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.ajo.2022.04.022_bib0007","doi-asserted-by":"crossref","first-page":"P41","DOI":"10.1016\/j.ophtha.2015.10.053","article-title":"Primary open-angle glaucoma Preferred Practice Pattern\u00ae guidelines","volume":"123","author":"Prum","year":"2016","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2022.04.022_bib0008","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/02713688109001850","article-title":"Reduction of intraocular pressure in normal and glaucomatous primate (Aotus trivirgatus) eyes by topically applied prostaglandin F 2\u03b1","volume":"1","author":"Camras","year":"1981","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.ajo.2022.04.022_bib0009","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1001\/archopht.1992.01080240073034","article-title":"Intraocular pressure reduction with PhXA34, a new prostaglandin analogue, in patients with ocular hypertension","volume":"110","author":"Camras","year":"1992","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2022.04.022_bib0010","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0161-6420(96)30749-5","article-title":"Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group","volume":"103","author":"Camras","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2022.04.022_bib0011","first-page":"513","article-title":"Preclinical pharmacology of latanoprost, a phenyl-substituted PGF2 alpha analogue","volume":"23","author":"Stjernschantz","year":"1995","journal-title":"Adv Prostaglandin Thromboxane Leukot Res"},{"key":"10.1016\/j.ajo.2022.04.022_bib0012","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/0014-4835(88)90043-7","article-title":"Morphological study of the anterior segment of cynomolgus monkey eyes following treatment with prostaglandin F2\u03b1","volume":"47","author":"L\u00fctjen-Drecoll","year":"1988","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ajo.2022.04.022_bib0013","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0014-4835(89)90011-0","article-title":"Increased uveoscleral outflow as a possible mechanism of ocular hypotension caused by prostaglandin F2\u03b1-1-isopropylester in the cynomolgus monkey","volume":"48","author":"Nilsson","year":"1989","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ajo.2022.04.022_bib0014","first-page":"2214","article-title":"Prostaglandins alter extracellular matrix adjacent to human ciliary muscle cells in vitro","volume":"38","author":"Lindsey","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2022.04.022_bib0015","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1167\/iovs.02-1281","article-title":"Morphological changes in the anterior eye segment after long-term treatment with different receptor selective prostaglandin agonists and a prostamide","volume":"44","author":"Richter","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.ajo.2022.04.022_bib0016","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1089\/108076803322660440","article-title":"Topical application of a nitric oxide synthase inhibitor reduces intraocular pressure in rabbits with experimental glaucoma","volume":"19","author":"Giuffrida","year":"2003","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.ajo.2022.04.022_bib0017","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0022-3565(25)11469-9","article-title":"Nitrovasodilators as a new class of ocular hypotensive agents","volume":"260","author":"Nathanson","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.ajo.2022.04.022_bib0018","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1006\/exer.1994.1199","article-title":"Nitrovasodilator effects on intraocular pressure and outflow facility in monkeys","volume":"58","author":"Schuman","year":"1994","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ajo.2022.04.022_bib0019","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1076\/0271-3683(200006)2061-YFT511","article-title":"The effect of L-arginine on intraocular pressure in the human eye","volume":"20","author":"Chuman","year":"2000","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.ajo.2022.04.022_bib0020","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0002-9394(14)75085-8","article-title":"Organic nitrate therapy in glaucoma","volume":"90","author":"Wizemann","year":"1980","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2022.04.022_bib0021","doi-asserted-by":"crossref","first-page":"H631","DOI":"10.1152\/ajpheart.00111.2003","article-title":"Nitric oxide regulates retinal vascular tone in humans","volume":"285","author":"Dorner","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.ajo.2022.04.022_bib0022","article-title":"Retinal vasculature in glaucoma: a review","volume":"1","author":"Chan","year":"2017","journal-title":"BMJ Open Ophthalmol"},{"key":"10.1016\/j.ajo.2022.04.022_bib0023","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0140-6736(04)16257-0","article-title":"Tee Khaw P. Primary open-angle glaucoma","volume":"363","author":"Weinreb","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ajo.2022.04.022_bib0024","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3129\/i08-058","article-title":"Ocular blood flow in glaucoma","volume":"43","author":"Weinreb","year":"2008","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.ajo.2022.04.022_bib0025","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1350-9462(02)00008-3","article-title":"The impact of ocular blood flow in glaucoma","volume":"21","author":"Flammer","year":"2002","journal-title":"Prog Retin Eye Res"},{"issue":"4","key":"10.1016\/j.ajo.2022.04.022_bib0026","doi-asserted-by":"crossref","first-page":"70","DOI":"10.17116\/oftalma201913504170","article-title":"Evaluation of the effect of prostaglandin analogues and a carbonic anhydrase inhibitor\/\u03b2-blocker combination on the ocular blood flow in patients with primary open-angle glaucoma [in Russian]","volume":"135","author":"Kiseleva","year":"2019","journal-title":"Vestn Oftalmol"},{"key":"10.1016\/j.ajo.2022.04.022_bib0027","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.ophtha.2017.06.002","article-title":"Projection-resolved optical coherence tomography angiography of macular retinal circulation in glaucoma","volume":"124","author":"Takusagawa","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2022.04.022_bib0028","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ajo.2018.11.012","article-title":"Macula vessel density and thickness in early primary open-angle glaucoma","volume":"199","author":"Hou","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2022.04.022_bib0029","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/112067210201200109","article-title":"Decreased nitric oxide production in primary open-angle glaucoma","volume":"12","author":"Doganay","year":"2002","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ajo.2022.04.022_bib0030","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/j.ophtha.2018.05.006","article-title":"Macular and optic nerve head vessel density and progressive retinal nerve fiber layer loss in glaucoma","volume":"125","author":"Moghimi","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2022.04.022_bib0031","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.ophtha.2019.12.030","article-title":"Ganglion cell complex thickness and macular vessel density loss in primary open-angle glaucoma","volume":"127","author":"Hou","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2022.04.022_bib0032","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s00417-018-3945-5","article-title":"Increase in the OCT angiographic peripapillary vessel density by ROCK inhibitor ripasudil instillation: a comparison with brimonidine","volume":"256","author":"Chihara","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajo.2022.04.022_bib0033","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/IJG.0000000000001859","article-title":"Optical coherence tomography angiography vessel density changes in normal-tension glaucoma treated with carteolol, brimonidine, or dorzolamide","volume":"30","author":"Lin","year":"2021","journal-title":"J Glaucoma"},{"issue":"4","key":"10.1016\/j.ajo.2022.04.022_bib0034","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.1364\/OE.20.004710","article-title":"Split-spectrum amplitude-decorrelation angiography with optical coherence tomography","volume":"20","author":"Jia","year":"2012","journal-title":"Opt Express"},{"key":"10.1016\/j.ajo.2022.04.022_bib0035","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ajo.2019.05.024","article-title":"Projection-resolved optical coherence tomography angiography of the peripapillary retina in glaucoma","volume":"207","author":"Liu","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2022.04.022_bib0036","doi-asserted-by":"crossref","first-page":"e276","DOI":"10.1097\/IJG.0000000000001860","article-title":"Superficial and deep macula vessel density in healthy, glaucoma suspect, and glaucoma eyes","volume":"30","author":"El-Nimri","year":"2021","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ajo.2022.04.022_bib0037","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0002-8703(80)90112-X","article-title":"The clinical importance of cardioselectivity and lipophilicity in beta blockers","volume":"100","author":"Cruickshank","year":"1980","journal-title":"Am Heart J"},{"issue":"5","key":"10.1016\/j.ajo.2022.04.022_bib0038","first-page":"695","article-title":"Beta 1 and beta 2 adrenergic binding sites in bovine retina and retinal blood vessels","volume":"29","author":"Ferrari-Dileo","year":"1988","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.ajo.2022.04.022_bib0039","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000265251","article-title":"Action mechanism of timolol to lower the intraocular pressure in rabbits","volume":"15","author":"Watanabe","year":"1983","journal-title":"Ophthalmic Res"},{"issue":"1","key":"10.1016\/j.ajo.2022.04.022_bib0040","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/s12886-018-0976-y","article-title":"Optical coherence tomography angiography of the macula and optic nerve head: microvascular density and test-retest repeatability in normal subjects","volume":"18","author":"Lim","year":"2018","journal-title":"BMC Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2022.04.022_bib0041","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0143-4160(94)90051-5","article-title":"Nitric oxide decreases [Ca2+]i in vascular smooth muscle by inhibition of the calcium current","volume":"15","author":"Blatter","year":"1994","journal-title":"Cell Calcium"},{"issue":"4","key":"10.1016\/j.ajo.2022.04.022_bib0042","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF02850153","article-title":"Efficacy of latanoprost and timolol maleate in black and white patients","volume":"21","author":"Kitnarong","year":"2004","journal-title":"Adv Ther"},{"issue":"2","key":"10.1016\/j.ajo.2022.04.022_bib0043","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1089\/jop.1995.11.107","article-title":"Intraocular pressure after a two-week washout following long-term timolol or levobunolol","volume":"11","author":"Hong","year":"1995","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.ajo.2022.04.022_bib0044","doi-asserted-by":"crossref","unstructured":"Wu J-H, Moghimi S, Nishida T, et\u00a0al. Correlation of ganglion cell complex thinning with baseline deep and superficial macular vessel density in glaucoma. Br J Ophthalmol. Published online January 31. doi:10.1136\/bjophthalmol-2021-320663.","DOI":"10.1136\/bjophthalmol-2021-320663"},{"issue":"11","key":"10.1016\/j.ajo.2022.04.022_bib0045","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1097\/IJG.0000000000001647","article-title":"Impact of pupil dilation on optical coherence tomography angiography retinal microvasculature in healthy eyes","volume":"29","author":"Villatoro","year":"2020","journal-title":"J Glaucoma"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293942200174X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293942200174X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:50:47Z","timestamp":1757598647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000293942200174X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":45,"alternative-id":["S000293942200174X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2022.04.022","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the Effects of Latanoprostene Bunod and Timolol on Retinal Blood Vessel Density: A Randomized Clinical Trial","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2022.04.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}